5-iodo-2H,3H-furo[2,3-b]pyridine | 2383276-33-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-iodo-2H,3H-furo[2,3-b]pyridine
• 英文别名: 5-iodo-2,3-dihydrofuro[2,3-b]pyridine
• CAS: 2383276-33-1
• 化学式: C₇H₆INO
• 分子量: 247.03
• InChiKey: BKDPSJJWVDAQRD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] SUBSTITUTED L,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES<br/>[FR] L,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES SUBSTITUÉES
  申请人：ZENO ROYALTIES & MILESTONES LLC

  公开号：WO2019173082A1

  公开（公告）日：2019-09-12

  Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
• [EN] COMBINATIONS<br/>[FR] COMBINAISONS
  申请人：RECURIUM IP HOLDINGS LLC

  公开号：WO2021127039A1

  公开（公告）日：2021-06-24

  Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor, and a SERD or SERM inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
• [EN] COMBINATIONS<br/>[FR] ASSOCIATIONS
  申请人：RECURIUM IP HOLDINGS LLC

  公开号：WO2021127045A1

  公开（公告）日：2021-06-24

  Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a Bcl-2 inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
• [EN] MONO- AND COMBINATION THERAPIES<br/>[FR] MONOTHÉRAPIES ET POLYTHÉRAPIES
  申请人：RECURIUM IP HOLDINGS LLC

  公开号：WO2021231653A1

  公开（公告）日：2021-11-18

  Disclosed herein are compounds and combinations of compounds for treating a disease or condition, such as cancer.